{
 "drug": "Rivaroxaban For Suspension",
 "asOf": "2026-10-09",
 "status": "discontinuing",
 "since": "09/18/2026",
 "dayN": 21,
 "cat": "Hematology",
 "companies": [
  "Janssen Pharmaceuticals"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "09/18/2026",
   "update_type": "New",
   "initial_posting_date": "09/18/2026",
   "package_ndc": "50458-575-01",
   "generic_name": "Rivaroxaban For Suspension",
   "contact_info": "800-526-7736",
   "related_info": "Business Decision",
   "openfda": {
    "application_number": [
     "NDA215859"
    ],
    "brand_name": [
     "XARELTO"
    ],
    "generic_name": [
     "RIVAROXABAN"
    ],
    "manufacturer_name": [
     "Janssen Pharmaceuticals, Inc."
    ],
    "product_ndc": [
     "50458-575",
     "50458-577",
     "50458-580",
     "50458-578",
     "50458-579",
     "50458-584"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "RIVAROXABAN"
    ],
    "rxcui": [
     "1114198",
     "1114202",
     "1232082",
     "1232084",
     "1232086",
     "1232088",
     "1549682",
     "1549683",
     "2059015",
     "2059017",
     "2588062",
     "2588066"
    ],
    "spl_id": [
     "5294926b-7812-41da-a0e8-56f492198450"
    ],
    "spl_set_id": [
     "10db92f9-2300-4a80-836b-673e1ae91610"
    ],
    "package_ndc": [
     "50458-577-60",
     "50458-577-18",
     "50458-577-14",
     "50458-577-01",
     "50458-577-10",
     "50458-580-01",
     "50458-580-10",
     "50458-580-30",
     "50458-580-07",
     "50458-580-90",
     "50458-578-01",
     "50458-578-10",
     "50458-578-30",
     "50458-578-90",
     "50458-578-14",
     "50458-578-07",
     "50458-579-01",
     "50458-579-10",
     "50458-579-30",
     "50458-579-90",
     "50458-579-99",
     "50458-579-07",
     "50458-579-89",
     "50458-584-51",
     "50458-584-52",
     "50458-575-01"
    ],
    "nui": [
     "N0000175635",
     "N0000175637"
    ],
    "pharm_class_moa": [
     "Factor Xa Inhibitors [MoA]"
    ],
    "pharm_class_epc": [
     "Factor Xa Inhibitor [EPC]"
    ],
    "unii": [
     "9NDF7JZ4M3"
    ]
   },
   "update_date": "09/18/2026",
   "therapeutic_category": [
    "Hematology"
   ],
   "presentation": "Xarelto, For Suspension, 155 mg (NDC 50458-575-01)",
   "company_name": "Janssen Pharmaceuticals",
   "status": "To Be Discontinued"
  }
 ],
 "firstSeen": "2026-09-23",
 "history": [
  {
   "date": "2026-09-23",
   "kind": "new",
   "to": "discontinuing",
   "text": "Rivaroxaban For Suspension appeared on the FDA shortage list (being discontinued)"
  }
 ]
}